Akari Therapeutics

AKTX | NASDAQ

Price Alert Chart Builder DCF Calculator

$8.10

-$0.15 (-1.82%)

Nov 2, 2026, 10:33 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020
Cash & Equivalents	5.2M	2.6M	3.85M	13.25M	9.36M	14.06M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	0	n/a
Receivables	n/a	201K	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	74K	60K	197K	100K	90.3K	229.2K
Total Current Assets	5.46M	2.95M	4.34M	13.82M	11.63M	14.58M
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	42.43M	47.61M	14K	17K	22.93K	27.15K
Total Long-Term Assets	42.43M	47.61M	14K	17K	22.93K	27.15K
Total Assets	47.89M	50.56M	4.36M	13.83M	11.65M	14.6M
Account Payables	8.77M	12.41M	1.67M	947K	1.79M	3.38M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	754K	3.26M	n/a	n/a	n/a	n/a
Other Current Liabilities	1.27M	1.58M	2.73M	7.95M	1.12M	n/a
Total Current Liabilities	12.35M	19.91M	4.58M	12.04M	6.09M	5.22M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	261K	383K	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	7.21M	8.42M	n/a	n/a	n/a	n/a
Total Liabilities	19.56M	28.33M	4.58M	12.04M	6.09M	5.22M
Total Debt	754K	3.26M	n/a	n/a	n/a	n/a
Book Value	28.33M	22.23M	-229K	1.79M	5.55M	9.38M
Book Value Per Share	1.35K	3.72K	-93.58	1.15K	5.18K	11.89K
Common Stock	n/a	5.32M	1.32M	745K	475.97K	384.73K
Retained Earnings	-264.55M	-247.25M	-227.46M	-217.45M	-199.71M	-182.28M
Comprehensive Income	-782K	-738K	51.15M	51.42M	51.65M	-648.07K
Shareholders Equity	28.33M	22.23M	-229K	1.79M	5.55M	9.38M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a